Resilience

We understand what propels you – efficiency, quality, and flexibility. With accelerated path to clinic, simplified tech transfer, and innovative expressions and manufacturing platforms, we can propel your biologics program to its next milestone. Learn how Resilience can support your biologic: https://hubs.ly/Q02N2PcB0 #biologics #biologicsdevelopment #biologicsmanufacturing

Home to our Development and Manufacturing Center for Biologics and Vaccines, our Alachua site is answering the call to revolutionize how medicines are made, funded, and scaled. Alachua houses process development, scale up, and cGMP manufacturing capabilities for vaccines, biologics, and plasmids. It also features specialty capabilities in cell line management, including mammalian, microbial, insect cells, single-use bioreactors up to 2000L, and small batch fill/ finish. Interested in learning more? Experience our Alachua, Florida site in a whole new way, at your own speed and at your fingertips, today with a virtual tour: https://hubs.ly/Q02L6PvC0 

We will be participating in Alliance for Regenerative Medicine's Cell-Based Immuno-Oncology Workshop in Philadelphia this week, and we’re excited to spotlight Eytan Abraham from Resilience, who will be a panelist on the Manufacturing & Scaling Considerations discussion. Join September 6, either in person or virtually, to gain insights into the future of adoptive cell therapy and cellular immunotherapies. This is a unique chance to hear from Eytan and other industry leaders about the challenges and innovations in manufacturing and scaling. Panel on Manufacturing & Scaling Considerations: - Moderator: Bruce Thompson, Kincell Bio - Panelists: Eytan Abraham, Resilience; Christopher Heery, Arcellx; Audrey Greenberg, SK pharmteco; William Zhou, Johnson & Johnson Don’t miss this opportunity to connect with top experts and explore the future of cell-based immuno-oncology!

Sleep better knowing your supply chain is in good hands with Build Your Resilience™. Our personalized, secondary supplier services are tailored to meet your unique needs. Engage with our procurement, logistics, commercial, and quality teams with the flexibility to scale, all without the worry of an annual commitment. Whether it's late-phase or commercial programs, we support both established and emerging modalities so you can focus on what matters most. Supply chain issues can be a nightmare, but with Build Your Resilience™, you can take back control. See how: https://hubs.ly/Q02LgsKr0

Debleena Dasgupta, Evan Pasenello, and Uzair Beg are excited to be back at BioProcess International September 23-26 in Boston, MA, as part of Biotech Week Boston! If you’re attending the event, be sure to stop in to see them at booth #906 to learn how we can support your next development or manufacturing program. We’ll see you soon! Interested in booking 1-1 time to discuss an opportunity further? Schedule a meeting: https://hubs.ly/Q02N3LVC0

As a multi-product and multiple modality facility with end-to-end services, our Toronto, Canada site is fully equipped to support the development and manufacturing of clinical and commercial products. With process and analytical development capabilities for vaccines, mAbs, small molecules, and more, flexible manufacturing up to 2000L, and formulation, filling, inspection, and labeling on site, our Toronto facility has built expertise in complex and commercial biopharmaceutical products. Learn more about our Toronto, Canada facility on a virtual tour today! Explore in an interactive 360 environment to see if Resilience could be the right fit for your next program: https://hubs.ly/Q02L6vb50

In an industry where time is of the essence, our Idea to Clinic™ offering is designed to expedite the process, helping our customers navigate the complexities of drug development and manufacturing with speed and efficiency. With our one-stop-shop approach, we're empowering our partners to build therapeutics right from the inception stage, eliminating unnecessary delays and streamlining the entire manufacturing timeline. Our goal? To reduce the manufacturing timeline by ~ 30% compared to the industry standard, bringing life-changing treatments to patients faster than ever before. Discover how our Idea to Clinic program can expedite the process without compromising product quality: https://hubs.ly/Q02N2Q5v0 #Resilience #Biologics #First-In-Human #Biomanufacturing

This Labor Day, we honor the dedication and contributions of our employees, whose efforts drive our success every day. Your resilience, collaboration, and commitment are the foundation of our progress, and we’re deeply grateful for all you do. Thank you for being an essential part of our journey. Wishing you a restful and well-deserved Labor Day. #LaborDay #Gratitude #Teamwork

Interested in exploring our Center of Excellence for fill/ finish and device assembly and packaging in Cincinnati, Ohio? Now you can experience a virtual tour of our Cincinnati facility from the comfort of your own office! Take a look at our FDA-licensed site, which currently offers high speed fill lines for vials, cartridges and pre-filled syringes (PFS), with additional line expansions coming online beginning in 2025. The facility is also expanding device assembly and packaging suites. This licensed site has a longstanding history of supplying commercial medicines worldwide. Take a tour today: https://hubs.ly/Q02L6zy90

At Resilience, we’re immunized against the status quo. Whether your discoveries originate from large pharma, small biotech/academic labs, or the research arms of NGOs, your vaccine deserves a forward-thinking and flexible partner for the pressing problems you’re seeking to solve. Let’s see where innovating together can take your program: https://hubs.ly/Q02MYyd50 #vaccines #vaccinedevelopment